A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Blokhin's Russian Cancer Research Center
UMC Utrecht
Neonc Technologies, Inc.
Barbara Ann Karmanos Cancer Institute
Adela, Inc
Mayo Clinic
University of Southern California
Servier
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
Apollomics Inc.
Columbia University
University of Sydney
Universitaire Ziekenhuizen KU Leuven
Second Affiliated Hospital of Guangzhou Medical University
Leiden University Medical Center
N.N. Petrov National Medical Research Center of Oncology
Kaohsiung Medical University Chung-Ho Memorial Hospital
Shanghai Yunying Medical Technology